Cerulean Pharma reported $31.89M in Equity Capital and Reserves for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Agile Therapeutics AGRX:US $ 10.68M 13.93M
Arrowhead Research ARWR:US $ 408.82M 28.07M
Bayer BAYN:GR € 31103M 714M
Biocept BIOC:US $ 40.06M 10.7M
Brainstorm Cell Therapeutics BCLI:US $ 24.93M 5.25M
Cerulean Pharma CERU:US $ 31.89M 24.14M
Immunogen IMGN:US $ 77.09M 8.63M
Macrogenics MGNX:US $ 291.44M 27.61M
Nektar Therapeutics NKTR:US $ 801.54M 103.44M
Perrigo Ordinary Shares PRGO:US $ 5182.4M 328.7M
Seattle Genetics SGEN:US $ 3164.96M 226.32M
YTE INCY:US $ 3148.66M 212.8M